Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland

被引:4
|
作者
Cypryk, Katarzyna [1 ]
Wender-Ozegowska, Ewa [2 ]
Cyganek, Katarzyna [3 ,4 ]
Sieradzki, Jacek [4 ]
Skoczylas, Kinga [5 ]
Chen, Xiaoxiao [6 ]
Cordero, Toni L. L. [6 ]
Shin, John [6 ]
Cohen, Ohad [7 ]
机构
[1] Med Univ Lodz, Dept Internal Dis & Diabetol, Pomorska Str 251, PL-92213 Lodz, Poland
[2] Poznan Univ Med Sci, Dept Reprod, Poznan, Poland
[3] Univ Hosp Krakow, Dept Metab Dis, Krakow, Poland
[4] Jagiellonian Univ Krakow, Coll Med, Krakow, Poland
[5] Medtronic, Warsaw, Poland
[6] Medtronic, Northridge, CA USA
[7] Medtronic, Tolochenaz, Switzerland
关键词
Type 1 diabetes-complicated pregnancy; HbA1c; Continuous subcutaneous insulin infusion (CSII); Continuous glucose monitoring (CGM); Large for gestational age (LGA); Neonatal outcomes; GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; OUTCOMES; INFUSION; RISK; MELLITUS; IMPLEMENTATION; KETOACIDOSIS; PREECLAMPSIA; ASSOCIATION;
D O I
10.1007/s00592-022-02020-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsThe effects of continuous subcutaneous insulin infusion (CSII) therapy with or without continuous glucose monitoring (CGM) on neonatal outcomes and glycemic outcomes of pregnant women with type 1 diabetes (T1D), living in Poland, were assessed.MethodsThis prospective observational study enrolled women with T1D (N = 481, aged 18-45 years) who were pregnant or planned pregnancy. All used CSII therapy and a subset used CGM with CSII (CSII + CGM). Neonatal outcomes (e.g., rate of large for gestational age [LGA] delivery [birth weight > 90th percentile]) and maternal glycemia (e.g., HbA1c and percentage of time at sensor glucose ranges) were evaluated.ResultsOverall HbA1c at trimesters 1, 2, and 3 was 6.8 +/- 1.1% (50.9 +/- 12.3 mmol/mol, N = 354), 5.8 +/- 0.7% (40.1 +/- 8.0 mmol/mol, N = 318), and 5.9 +/- 0.7% (41.4 +/- 8.0 mmol/mol, N = 255), respectively. A HbA1c target of < 6.0% (42 mmol/mol) at each trimester was achieved by 20.9% (74/354), 65.1% (207/318), and 58.0% (148/255), respectively. For women using CSII + CGM versus CSII only, HbA1c levels at trimesters 1, 2, and 3 were 6.5 +/- 0.9% versus 7.1 +/- 1.3% (47.8 +/- 9.7 mmol/mol versus 54.3 +/- 14.0 mmol/mol, p < 0.0001), 5.7 +/- 0.6% versus 6.0 +/- 0.9% (38.9 +/- 6.5 mmol/mol versus 41.6 +/- 9.3 mmol/mol, p = 0.0122), and 5.8 +/- 0.6% versus 6.1 +/- 0.8% (40.3 +/- 6.9 mmol/mol versus 42.9 +/- 9.1 mmol/mol, p = 0.0117), respectively. For the overall, CSII only, and CSII + CGM groups, rates of LGA delivery were 22.7% (74/326), 24.6% (34/138), and 21.3% (40/188), respectively.ConclusionsObservational assessment of women with T1D using CSII therapy demonstrated low HbA1c throughout pregnancy and low rates of LGA. The addition of CGM to CSII therapy compared to CSII therapy alone was associated with some improved maternal glycemic and neonatal outcomes.Clinicaltrials.gov identifierNCT01779141 (January 2013).
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [21] Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with Type 1 diabetes - an observational study
    Secher, A. L.
    Stage, E.
    Ringholm, L.
    Barfred, C.
    Damm, P.
    Mathiesen, E. R.
    DIABETIC MEDICINE, 2014, 31 (03) : 352 - 356
  • [22] REAL-TIME CONTINUOUS GLUCOSE MONITORING AS A TOOL TO PREVENT SEVERE HYPOGLYCAEMIA IN SELECTED PREGNANT WOMEN WITH TYPE 1 DIABETES - AN OBSERVATIONAL STUDY
    Secher, A.
    Stage, E.
    Ringhol, L.
    Barfred, C.
    Damm, P.
    Mathiesen, E. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A78 - A78
  • [23] The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
    T. Battelino
    I. Conget
    B. Olsen
    I. Schütz-Fuhrmann
    E. Hommel
    R. Hoogma
    U. Schierloh
    N. Sulli
    J. Bolinder
    Diabetologia, 2012, 55 : 3155 - 3162
  • [24] The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
    Battelino, T.
    Conget, I.
    Olsen, B.
    Schuetz-Fuhrmann, I.
    Hommel, E.
    Hoogma, R.
    Schierloh, U.
    Sulli, N.
    Bolinder, J.
    DIABETOLOGIA, 2012, 55 (12) : 3155 - 3162
  • [26] Intermittently scanned continuous glucose monitoring is associated with lower spontaneous abortion rate compared with conventional blood glucose monitoring in pregnant women with type 1 diabetes: An observational study
    Lemaitre, Madleen
    Faiz, Kenza
    Baudoux, Florence
    Subtil, Damien
    Vambergue, Anne
    DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (06):
  • [27] A retrospective study comparing the results of continuous glucose monitoring to self-blood glucose monitoring for pregnant women with type 1 diabetes mellitus
    Khan, Adeel Ahmad
    Ata, Fateen
    Alsharkawy, Naglaa Abdelaleem Al Sayed
    Othman, Eman Mahmoud Mohamed
    Hassan, Ifrah Mohamed
    Taha, Faten Altaher Mohd
    Baagar, Khaled
    Ali, Hamda
    Konje, Jutin C.
    Abou-Samra, Abdul Badi
    Bashir, Mohammed
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2024, 19 (05) : 429 - 435
  • [28] Retinal characteristics during 1year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study
    Klefter, Oliver Niels
    Hommel, Eva
    Munch, Inger Christine
    Norgaard, Kirsten
    Madsbad, Sten
    Larsen, Michael
    ACTA OPHTHALMOLOGICA, 2016, 94 (06) : 540 - 547
  • [29] Challenges and consequences of blood glucose monitoring in pregnant women with type 2 diabetes: An observational cohort study
    Glover, G.
    Lu, H.
    Thanabalasingham, G.
    Malakasis, A.
    Owen, K.
    Frise, C.
    Gibson, S.
    Holden, R.
    Burial, S.
    Hirst, J. E.
    DIABETIC MEDICINE, 2022, 39
  • [30] Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy
    Deiss, D
    Hartmann, R
    Hoeffe, J
    Kordonouri, O
    PEDIATRIC DIABETES, 2004, 5 (03) : 117 - 121